Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.23.10107

Association of a Pre-miR-27a Polymorphism with Cancer Risk: an Updated Meta-analysis  

Bai, Rong-Pan (Institute of Environmental Health, Zhejiang Univerisity School of Medicine)
Weng, Yu (Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang Univerisity School of Medicine)
Su, Li-Ling (Institute of Environmental Health, Zhejiang Univerisity School of Medicine)
Jin, Ming-Juan (Institute of Environmental Health, Zhejiang Univerisity School of Medicine)
Xu, Zheng-Ping (Institute of Environmental Health, Zhejiang Univerisity School of Medicine)
Lu, Li-Qin (Department of Oncology, Zhejiang Provincial People's Hospital)
Chen, Guang-Di (Institute of Environmental Health, Zhejiang Univerisity School of Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.23, 2015 , pp. 10107-10114 More about this Journal
Abstract
MicroRNA-27a is highly expressed in cancers and has been identified as an oncogenic microRNA. A genetic variant in pre-miR-27a (rs895819) with a transition of A to G has been demonstrated to be associated with cancer risk; however, the results of these studies remain conflicting rather than conclusive. Therefore, we performed a meta-analysis to derive a more precise estimation. Through searching PubMed or other databases up to March 2014 using the following MeSH terms and keywords, "miR-27a", "polymorphism" and "cancer", seventeen case-control studies were identified in this meta-analysis, including 7,813 cases and 9,602. Crude odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated to investigate the association strength between rs895819 and the susceptibility of cancer. The results of the overall meta-analysis did not suggest any association between rs895819 polymorphism and cancer susceptibility, and this remained in Asians as a subgroup. In Caucasians, however, the rs895819 was associated with a reduced cancer risk in heterozygous (OR, 0.83; 95%CI, 0.75-0.93) and dominant models (OR, 0.84; 95%CI, 0.76-0.93), and the [G] allele of rs895819 showed a protective effect (OR, 0.90, 95%CI, 0.84-0.97). Further studies showed a significant association between the [G] allele of rs895819 and decreased risk of breast cancer (0.91; 95%CI, 0.85-0.98), and stratified analyses indicated a protective effect of the [G] allele in Caucasians (OR, 0.89; 95%CI, 0.82-0.98), younger breast cancer cases (OR, 0.87; 95%CI, 0.79-0.96), and in the group of unilateral breast cancer patients (OR, 0.90; 95%CI, 0.83-0.97). These findings suggest an association between pre-miR-27a polymorphism rs895819 and cancer risk in Caucasians. The protective effect of rs895819 [G] allele in younger breast cancer and in the group of unilateral breast cancer patients await further confirmation since the included studies in this meta-analysis were limited.
Keywords
microRNA-27a; meta-analysis; polymorphism; cancer;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.   DOI
2 Catucci I, Verderio P, Pizzamiglio S, et al (2012). The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat, 133, 805-7.   DOI
3 Chen K, Rajewsky N (2006). Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet, 38, 1452-6.   DOI
4 Chen K, Song F, Calin GA, et al (2008). Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis, 29, 1306-11.   DOI   ScienceOn
5 Chen QH, Wang QB, Zhang B (2014). Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis. Tumour Biol, 35, 529-43.   DOI
6 Esteller M (2011). Non-coding RNAs in human disease. Nat Rev Genet, 12, 861-74.
7 Ge YF, Sun J, Jin CJ, et al (2013). AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo. Asian Pac J Cancer Prev, 14, 963-8.   과학기술학회마을   DOI   ScienceOn
8 Hayashino Y, Noguchi Y, Fukui T (2005). Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol, 15, 235-43.   DOI
9 Hezova R, Kovarikova A, Bienertova-Vasku J, et al (2012). Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol, 18, 2827-31.   DOI   ScienceOn
10 Hirota T, Date Y, Nishibatake Y, et al (2012). Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues. Lung Cancer, 77, 16-23.   DOI   ScienceOn
11 Jahid S, Sun J, Edwards RA, et al (2012). miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov, 2, 540-53.   DOI
12 Jazdzewski K, Murray EL, Franssila K, et al (2008). Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA, 105, 7269-74.   DOI
13 Ma XP, Zhang T, Peng B, et al (2013). Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS One, 8, 79584.   DOI
14 Kozomara A, Griffiths-Jones S (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 39, 152-7.
15 Kupcinskas J, Wex T, Link A, et al (2014). Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer. PLoS One, 9, 87467.   DOI
16 Li P (2011). Genetic associations of miRNA-SNPs with the common diseases and integrative analysis of "omics" data of hepatocellular carcinoma. Academy of Military Medical Sciences in the People's Liberation Army, [D] Beijing.
17 Mertens-Talcott SU, Chintharlapalli S, Li X, et al (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res, 67, 11001-11.   DOI
18 Pasquinelli AE (2012). MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet, 13, 271-82.
19 Ryan BM, Robles AI, Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer, 10, 389-402.   DOI
20 Saunders MA, Liang H, Li WH (2007). Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A, 104, 3300-5.   DOI   ScienceOn
21 Shi D, Li P, Ma L, et al (2012). A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One, 7, 46566.   DOI
22 Wang Z, Lai J, Wang Y, et al (2013). The Hsa-miR-27a rs895819 (A>G) polymorphism and cancer susceptibility. Gene, 521, 87-90.   DOI
23 Song MY, Su HJ, Zhang L, et al (2013). Genetic polymorphisms of miR-146a and miR-27a, H. pylori infection, and risk of gastric lesions in a Chinese population. PLoS One, 8, 61250.   DOI
24 Sun Q, Gu H, Zeng Y, et al (2010). Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci, 101, 2241-7.   DOI
25 Wang B, Ma N, Wang Y (2012). Association between the hsamir-27a variant and breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 6207-10.   과학기술학회마을   DOI   ScienceOn
26 Wei J, Zheng L, Liu S, et al (2013). MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol, 74, 1199-205.   DOI   ScienceOn
27 Wu XJ, Li Y, Liu D, et al (2013). miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 885-9.   과학기술학회마을   DOI
28 Xiong XD, Luo XP, Cheng J, et al (2014). A genetic variant in pre-miR-27a is associated with a reduced cervical cancer risk in southern Chinese women. Gynecol Oncol, 132, 450-4.   DOI
29 Xu J, Yin Z, Shen H, et al (2013a). A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One, 8, 79135.   DOI
30 Xu Q, He CY, Liu JW, et al (2013b). Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis. PLoS One, 8, 65208.   DOI
31 Yoon KA, Yoon H, Park S, et al (2012). The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg, 144, 794-807.   DOI
32 Yang Q, Jie Z, Ye S, et al (2014). Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene, 33, 193-202.   DOI
33 Yang R, Burwinkel B (2012). A bias in genotyping the miR-27a rs895819 and rs11671784 variants. Breast Cancer Res Treat, 134, 899-901.   DOI
34 Yang R, Schlehe B, Hemminki K, et al (2010). A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat, 121, 693-702.   DOI
35 Yuan L, Chu H, Wang M, et al (2013). Genetic variation in DROSHA 3'UTR regulated by hsa-miR-27b is associated with bladder cancer risk. PLoS One, 8, e81524.   DOI
36 Zanetti KA, Haznadar M, Welsh JA, et al (2012). 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Res, 72, 1467-77.   DOI
37 Zeng Y, Cullen BR (2003). Sequence requirements for micro RNA processing and function in human cells. RNA, 9, 112-23.   DOI
38 Zeng Y, Yi R, Cullen BR (2005). Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J, 24, 138-48.   DOI
39 Zhang M (2012). Study on the Associations of Lifestyle-related Factors, Gentic Variants in miRNA encoding regions and mirna binding sites with colorectal cancer risk. Zhejiang University, [D] Zhejiang.
40 Zhang M, Jin M, Yu Y, et al (2012). Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care, 21, 274-80.
41 Zhang N, Huo Q, Wang X, et al (2013). A genetic variant in pre-miR-27a is associated with a reduced breast cancer risk in younger Chinese population. Gene, 529, 125-30.   DOI
42 Zhang P (2011). Polymorphisms of MicroRNA and ESR1 genes and their association with triple negative breast cancer risk and prognosis. Chinese Academy of Medical Sciences (Beijing Union Medical College), [D] Beijing.
43 Zhong S, Chen Z, Xu J, et al (2013). Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep, 40, 3181-6.   DOI
44 Zhou Y, Du WD, Chen G, et al (2012). Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol, 138, 939-45.   DOI